21825-15-0

Upstream product

• 4755-77-5 Ethyl oxalyl chloride 
• 106-50-3 1,4-phenylenediamine 
• 95-92-1 oxalic acid diethyl ester 

Downstream Products

• 24261-52-7 N-{4-[(2-Ethyl-hexyloxyoxalyl)-amino]-phenyl}-oxalamic acid 2-ethyl-hexyl ester 
• 24200-41-7 N-{4-[(2-Methoxy-ethoxyoxalyl)-amino]-phenyl}-oxalamic acid 2-methoxy-ethyl ester 
• 24261-53-8 N-{4-[(2-Ethyl-butoxyoxalyl)-amino]-phenyl}-oxalamic acid 2-ethyl-butyl ester 
• 24200-47-3 N-{4-[(3-Phenyl-propoxyoxalyl)-amino]-phenyl}-oxalamic acid 3-phenyl-propyl ester 
• 24200-46-2 N-[4-(Butoxyoxalyl-amino)-phenyl]-oxalamic acid butyl ester 
• 105428-49-7 di-(4-hydroxyanilide) of 1,4-phenylenedioxamic acid 
• 105428-50-0 C₂₄H₁₈N₄O₈ 
• 18505-15-2 N,N'-1,4-phenylenebis(2-thiooxamic acid ethyl ester) 
• 105428-51-1 N-(2-Chloro-ethyl)-N'-{4-[(2-chloro-ethylaminooxalyl)-amino]-phenyl}-oxalamide 
• 53882-03-4 N,N'-p-phenylene-bis-oxalamic acid 
• 24200-57-5 N-{4-[(1,3-Dimethyl-butoxyoxalyl)-amino]-phenyl}-oxalamic acid 1,3-dimethyl-butyl ester 

Relevant academic research and scientific papers

Long-range magnetic coupling through extended π-conjugated aromatic bridges in dinuclear copper(II) metallacyclophanes

Self-assembly of 1,4-phenylenebis(oxamate) and 4,4′-biphenylenebis(oxamate) ligands and Cu2+ ions gives two new dinuclear copper(II) metallacyclophanes where the two metal centers are connected by double para-substituted aromatic diamide bridge

Synthesis and cytotoxic activities of organometallic Ru(II) diamine complexes

A series of mono and bimetallic ruthenium(II) arene complexes bearing diamine (Ru1-6) were prepared and fully characterized by 1H, 13C, 19F, and 31P NMR spectroscopy and elemental analysis. The crysta

Dicopper(II) metallacyclophanes with electroswitchable polymethyl- substituted para-phenylene spacers

Double-stranded anionic dinuclear copper(II) metallacyclic complexes of the paracyclophane type [Cu2L2]4- have been prepared by the CuII-mediated self-assembly of different para-phenylenebis(oxamato) bridging li

Triphenylphosphine-mediated reaction between dimethyl acetylenedicarboxylate and NH-acids derived from diaminobenzenes

Protonation of the 1:1 adduct produced in the reaction between triphenylphosphine and dimethyl acetylenedicarboxylate with ethyl 2-[(2-{[2-(ethyloxy)-2-oxoacetyl]amino}phenyl}amino]-2-oxoethanoate leads to a vinylphosphonium salt, which undergoes an inter

Oxamic acid derivatives

Anti-allergic agents of aromatic and heterocyclic oxamic acid derivation present the following formula: STR1 in which A is a member selected from the group consisting of 2-thiazolyl, 2-pyridyl, 2-pyridyl-N-oxide, 6-(lower)alkyl-2-pyridyl, 3-cyano-2-pyridyl, 3-pyridyl, 4-pyridyl, 2-pyrimidinyl, 2-pyrazinyl, α-naphthyl, β-naphthyl, phenyl, 2,6-di-chlorophenyl, and substituted phenyl moieties containing from one to three substituents in any of the 2,3,4 and 5 positions of the phenyl ring, independently selected from the group consisting of lower alkyl, lower alkylthio, lower alkylsulfinyl, lower alkoxy, hydroxy(lower)alkoxy, 2-(lower alkoxy oxalyloxy) ethoxy, benzyloxy, N-mono-and di-lower alkylamino(lower)alkoxy, halo, sulfamyl, polyhalo(lower)alkyl, carbamyl, N-lower alkylcarbamyl, nitro, mono-and di-lower alkylamino, phenylazo, carboxy, lower alkylcarbonyl, cyano, carb(lower)alkoxy, phenoxy(lower)alkoxy, lower alkoxyoxalamido and lower alkoxyoxalamidophenoxy radicals; B, when taken alone, is a member selected from the group consisting of --OH, lower alkoxy, --NH2, --NHOH, cyclohexyloxy and phenoxy; and Y is a member selected from the group consisting of oxygen and when taken with B and the carbon atom to which they are attached, forms the moiety STR2

Pyridyl oxamic acid derivatives and use in the prevention of allergic reactions

Anti-allergic agents of aromatic and heterocyclic oxamic acid derivation present the following formula: STR1 in which A is a member selected from the group consisting of 2-thiazolyl, 2-pyridyl, 2-pyridyl-N-oxide, 6-(lower)alkyl-2-pyridyl, 3-cyano-2-pyridyl, 3-pyridyl, 4-pyridyl, 2-pyrimidinyl, 2-pyrazinyl, α-naphthyl, βnaphthyl, phenyl, 2,6-dichlorophenyl, and substituted phenyl moieties containing from one to three substituents in any of the 2,3,4 and 5 positions of the phenyl ring, independently selected from the group consisting of lower alkyl, lower alkylthio, lower alkylsulfinyl, lower alkoxy, hydroxy(lower)-alkoxy, 2-(lower alkoxy oxalyloxy) ethoxy, benzyloxy, N-mono-and di-lower alkylamino(lower)-alkoxy, halo, sulfamyl, polyhalo(lower)alkyl, carbamyl, N-lower alkylcarbamyl, nitro, mono-and di-lower alkylamino, phenylazo, carboxy, lower alkylcarbonyl, cyano, carb(lower)alkoxy, phenoxy(lower)alkoxy, lower alkoxyoxalamido and lower alkoxyoxalamidophenoxy radicals; B, when taken alone, is a member selected from the group consisting of --OH, lower alkoxy, --NH2, --NHOH, cyclohexyloxy and phenoxy; and Y is a member selected from the group consisting of oxygen and when taken with B and the carbon atom to which they are attached, forms the moiety STR2

Oxamic acid derivatives for the prevention of immediate type hypersensitivity reactions

Anti-allergic agents of EQU1 and heterocyclic oxamic acid derivation present the following formula: IN WHICH A is a member selected from the group consisting of 2-thiazolyl, 2-pyridyl, 2-pyridyl-N-oxide, 6-(lower)alkyl-2-pyridyl, 3-cyano-2-pyridyl, 3-pyridyl, 4-pyridyl, 2-pyrimidinyl, 2-pyrazinyl, α-naphthyl, β-naphthyl, phenyl, 2,6-dichlorophenyl, and substituted phenyl moieties containing from one to three substituents in any of the 2,3,4 and 5 positions of the phenyl ring, independently selected from the group consisting of lower alkyl, lower alkylthio, lower alkylsulfinyl, lower alkoxy, hydroxy(lower)-alkoxy, 2-(lower alkoxy oxalyloxy) ethoxy, benzyloxy, N-mono-and di-lower alkylamino(lower)-alkoxy, halo, sulfamyl, polyhalo(lower)alkyl, carbamyl, N-lower alkylcarbamyl, nitro, mono- and di-lower alkylamino, phenylazo, carboxy, lower alkylcarbonyl, cyano, carb(lower)alkoxy, phenoxy(lower)alkoxy, lower alkoxyoxalamido and lower alkoxyoxalamidophenoxy radicals; B, when taken alone, is a member selected from the group consisting of -OH, lower alkoxy, --NH2, --NHOH, cyclohexyloxy and phenoxy; and Y is a member selected from the group consisting of oxygen and when taken with B and the carbon atom to which they are attached, forms the moiety EQU2

Cyano phenylene dioxamic molecules

Compounds represented below SPC1 And pharmaceutical compositions thereof, the compositions including the non-substituted phenylene dioxamates are useful in the prophylactic treatment of sensitized mammals for allergy and all anaphylactic reactions of a reagin or non-reagin mediated nature.

Oxanilic acids, a new series of orally active antiallergic agents

A large number of oxanilic acid esters and N heteroaryl oxamic acid esters were prepared and found to have antiallergic activity using the rat passive cutaneous anaphylaxis (PCA) test. Many of the oxanilic acid esters are active orally, with the most active species having an aryl 2' carbamoyl group and a 3' methoxy group. Hydrolysis of the ester from the oxanilic ester moiety causes a loss of oral activity.